BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
-11.11%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.07B
AUM Growth
-$1.54B
(-18%)
Cap. Flow
-$234M
Cap. Flow
% of AUM
-3.31%
Top 10 Holdings %
Top 10 Hldgs %
34.72%
Holding
187
New
10
Increased
57
Reduced
82
Closed
15
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$58.1M |
| 2 |
Pfizer
PFE
|
$41.4M |
| 3 |
Harmony Biosciences
HRMY
|
$28.1M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$25.4M |
| 5 |
Celldex Therapeutics
CLDX
|
$24.9M |
Top Sells
| 1 |
Elevance Health
ELV
|
$98M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$85.7M |
| 3 |
AbbVie
ABBV
|
$47.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
$46.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$42.9M |
Sector Composition
| 1 | Healthcare | 98.26% |
| 2 | Industrials | 0.38% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
C4 Therapeutics
CCCC
$185M
| – | – |
-54,500
| Closed | -$1.32M |
|
177
IDEAYA Biosciences
IDYA
$2.23B
| – | – |
-46,200
| Closed | -$517K |
|
178
Kymera Therapeutics
KYMR
$2.92B
| – | – |
-52,400
| Closed | -$2.22M |
|
179
NIO
NIO
$13.8B
| – | – |
-1,093
| Closed | -$23K |
|
180
Pinduoduo
PDD
$177B
| – | – |
-466
| Closed | -$19K |
|
181
Quanterix
QTRX
$202M
| – | – |
-35,704
| Closed | -$1.04M |
|
182
TSMC
TSM
$1.21T
| – | – |
-619
| Closed | -$65K |
|
183
United Microelectronic
UMC
$17.2B
| – | – |
-2,698
| Closed | -$25K |
|
184
Dentsply Sirona
XRAY
$2.85B
| – | – |
-159,129
| Closed | -$7.83M |
|
|
MRTX
185
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-14,800
| Closed | -$1.22M |
|
|
GTH
186
DELISTED
Genetron Holdings Limited ADS
GTH
| – | – |
-178,607
| Closed | -$1.17M |
|
|
BHVN
187
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-39,207
| Closed | -$4.65M |
|